BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25581730)

  • 21. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
    Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W
    Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
    Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
    Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice.
    Kluk MJ; Ho C; Yu H; Chen BJ; Neuberg DS; Dal Cin P; Woda BA; Pinkus GS; Rodig SJ
    Am J Clin Pathol; 2016 Feb; 145(2):166-79. PubMed ID: 26834124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets.
    Agostinelli C; Rizvi H; Paterson J; Shende V; Akarca AU; Agostini E; Fuligni F; Righi S; Spagnolo S; Piccaluga PP; Clark EA; Pileri SA; Marafioti T
    Am J Surg Pathol; 2014 Oct; 38(10):1349-59. PubMed ID: 25118816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressive B-cell lymphomas: frequency, immunophenotype, and genetics in a reference laboratory population.
    Naeini YB; Wu A; O'Malley DP
    Ann Diagn Pathol; 2016 Dec; 25():7-14. PubMed ID: 27806850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggressive B cell lymphomas of the gastrointestinal tract: clinicopathologic and genetic analysis.
    Choi SY; Kim SJ; Kim WS; Kim K; Ko YH
    Virchows Arch; 2011 Nov; 459(5):495-502. PubMed ID: 22002677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
    Gualco G; Weiss LM; Barber GN; Bacchi CE
    Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Patients with MYC-Altered Lymphomas.
    Landsburg DJ
    Curr Hematol Malig Rep; 2016 Jun; 11(3):208-17. PubMed ID: 26983958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene.
    Lima FP; Bousquet M; Gomez-Brouchet A; de Paiva GR; Amstalden EM; Soares FA; Dastugue N; Vassallo J; Brousset P
    Am J Clin Pathol; 2008 May; 129(5):723-6. PubMed ID: 18426731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution and ZAP-70 expression of WHO lymphoma categories in Shanxi, China: a review of 447 cases using a tissue microarray technique.
    Wang J; Young L; Win W; Taylor CR
    Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):323-32. PubMed ID: 16280661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-resolution architecture and partner genes of
    Chong LC; Ben-Neriah S; Slack GW; Freeman C; Ennishi D; Mottok A; Collinge B; Abrisqueta P; Farinha P; Boyle M; Meissner B; Kridel R; Gerrie AS; Villa D; Savage KJ; Sehn LH; Siebert R; Morin RD; Gascoyne RD; Marra MA; Connors JM; Mungall AJ; Steidl C; Scott DW
    Blood Adv; 2018 Oct; 2(20):2755-2765. PubMed ID: 30348671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.
    Haralambieva E; Boerma EJ; van Imhoff GW; Rosati S; Schuuring E; Müller-Hermelink HK; Kluin PM; Ott G
    Am J Surg Pathol; 2005 Aug; 29(8):1086-94. PubMed ID: 16006805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma.
    Smith SM; Anastasi J; Cohen KS; Godley LA
    Blood Cells Mol Dis; 2010 Dec; 45(4):317-23. PubMed ID: 20817505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
    Green TM; Young KH; Visco C; Xu-Monette ZY; Orazi A; Go RS; Nielsen O; Gadeberg OV; Mourits-Andersen T; Frederiksen M; Pedersen LM; Møller MB
    J Clin Oncol; 2012 Oct; 30(28):3460-7. PubMed ID: 22665537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical Profile of MYC Protein in Pediatric Small Round Blue Cell Tumors.
    Chisholm KM; Krishnan C; Heerema-McKenney A; Natkunam Y
    Pediatr Dev Pathol; 2017 Jun; 20(3):213-223. PubMed ID: 28521631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
    Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
    J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathology consultation on intermediate-to-large B-cell lymphomas.
    Montgomery ND; Fedoriw Y
    Am J Clin Pathol; 2014 Mar; 141(3):305-17. PubMed ID: 24515757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomorphologic findings of B-cell lymphomas with concurrent IGH/BCL2 and MYC rearrangements (dual-translocation lymphomas).
    da Cunha Santos G; Ko HM; Saieg MA; Boerner SL; Lai SW; Bailey D; Geddie WR
    Cancer Cytopathol; 2011 Aug; 119(4):254-62. PubMed ID: 21560251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection.
    Muñoz-Mármol AM; Sanz C; Tapia G; Marginet R; Ariza A; Mate JL
    Histopathology; 2013 Sep; 63(3):418-24. PubMed ID: 23795946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytopathology of "double-hit" non-Hodgkin lymphoma.
    Elkins CT; Wakely PE
    Cancer Cytopathol; 2011 Aug; 119(4):263-71. PubMed ID: 21560252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.